|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | COX-2 in cardiovascular disease 显示文摘 | Bailey DB Mitchell JA Warner TD | 2006 | Arterioscler Thromb Vasc Biol2006，26，： | 1 |
| 2 | COX-2 selectivity alone dose not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs显示文摘 | WARNER TD MITCHELL JA | 2008 | Lancet2008，371，9608： | 1 |
| 3 | A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose显示文摘 | Reynolds TD Dasbach TP | 2003 | Int J Pharm2003，250，1： | 1 |
| 4 | Cyclooxygenase-2: Pharmacology, physiology, biochemistry and relevance to NSAID therapy 显示文摘 | Warner TD | 1999 | Br J Pharmacolo1999，128，： | 1 |
| 5 | Cyeloxygenase-3 (COX-3): Filling in the gaps toward a COX continuum? 显示文摘 | Mitchell JA | 2002 | Proc Natl Acad Sci USA2002，99，13： | 1 |
| 6 | Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy 显示文摘 | Mitchell JA Warner TD | 1999 | Br J Pharmacol1999，128，6： | 1 |
| 7 | Cyclooxygenase-2:pharmacology,physiology,biochemistry and relevance to NSAID therapy显示文摘 | MITCHELL JA WARNER TD | 1999 | Br J Pharmacol1999，128，： | 1 |
| 8 | Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy 显示文摘 | Mitchell JA Wamer TD | 1999 | BrJ Pharmacol1999，128，6： | 1 |
| 9 | COX-2 in Cardiovascular Disease显示文摘 | Bailey DB Mitchell JA Warner TD | 2006 | Arterioscler Thromb Vasc Biol2006，26，： | 1 |
| 10 | Cyclo - oxygenase - 2: pharmacology, physiolo gy, biochemistry and relavence to NSAID therapy显示文摘 | Mitchell JA Warner TD | | 0，，： | 1 |
| 11 | An improved method ofconstructing a database of monthly climate observationsand associated high -resolution grids 显示文摘 | Mitchell TD Jones PD | 2005 | InternationalJournal of Climatology2005，25，： | 1 |
| 12 | Cyclooxygenase-3 (COX-3):Filling in the gaps towaal a COX continuum显示文摘 | Wamer TD Mitchell JA | 2002 | Proc Natl Acad Sci USA2002，99，13： | 1 |
| 13 | Native LDL inhibits the re- lease of endothelial derived relaxing factor by reducing the activity of endohelial nit ricoxide synthase 显示文摘 | Mitchell JA Warner TD Huang Z | | J Vase Res0，29，： | 1 |
| 14 | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis显示文摘 | Warner TD Giuliano F Vojnovic I Bucasa A Mitchell JA Vane JR | 1999 | Proc Natl Acad Sci USA1999，96，： | 1 |
| 15 | Cyclooxygenase-2:Pharmacology,physiology,biochemistry and relevance to MAID therapy显示文摘 | Mitchell JA Warner TD | 1999 | Br J Pharma-solo1999，128，： | 1 |
| 16 | Cyclooxygenase-3 (COX-3): filling in the gaps toward a COXcontinuum显示文摘 | Warner TD Mitchell JA | 2002 | Proc Natl Acad Sci USA2002，99，13： | 1 |
| 17 | COX - 2 selectivity alone dose not define the cardiovascular risks associated with non - steroidal anti - inflammatory drugs显示文摘 | Warner TD Mitchell JA | 2008 | Lancet2008，371，9608： | 1 |
| 18 | Metabolic responses to leptin in obese db/db mice are strain dependent显示文摘 | Harris RB Mitchell TD Yan X | 2001 | Am J Physiol Regul Integr Comp Physiol2001，281，： | 1 |
| 19 | Cyclooxygenase-2: pharmacology,physiology, biochemistry and relevance to NSAID therapy显示文摘 | MITCHELL JA WARNER TD | 1999 | Br J Pharmacol1999，128，6： | 1 |
| 20 | Weight loss in ratsexposed to repeated acute restraint stress is independent ofenergy or leptin status显示文摘 | Harris RB Mitchell TD Simpson J | 2002 | Am J Physiol Regul Integr CompPhysiol2002，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员